Attached files

file filename
S-1 - S-1 - Radius Health, Inc.a2204572zs-1.htm
EX-23.1 - EX-23.1 - Radius Health, Inc.a2204572zex-23_1.htm

Exhibit 10.67

 

AMENDMENT NO. 1
TO
SERIES A-1 CONVERTIBLE PREFERRED
STOCK PURCHASE AGREEMENT

 

This AMENDMENT NO. 1 TO SERIES A-1 CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (this “Amendment No. 1”) is entered into as of the 11th day of May, 2011, to amend that certain Series A-1 Convertible Preferred Stock Purchase Agreement dated April 25, 2011, by and among Radius Health, Inc., a Delaware corporation (the “Corporation”) and each of the Investor parties named therein. Capitalized terms used but not defined herein shall have the meaning ascribed thereto in the Agreement.

 

WHEREAS, the parties to the Agreement (the “Parties”) have entered into the Agreement for, among other things, the purchase and sale shares of the Corporation’s Series A-1 Preferred Stock;

 

WHEREAS, the Parties acknowledge and agree that it is in the best interest of the Parties to eliminate certain conditions precedent and subsequent to the Stage I Closing, Stage II Closing and the Stage III Closing, as set forth herein; and

 

WHEREAS, the Parties wish to amend the Agreement as set forth herein.

 

NOW, THEREFORE, in consideration of the agreements herein and in the Agreement and in reliance upon the representations and warranties herein and therein, the parties hereto, intending to be legally bound, hereby agree as follows:

 

1.             Section 7.1 of the Agreement is hereby amended by deleting Section 7.1 in its entirety and replacing it with the following:  “7.1 RESERVED. “

 

2.             Section 7.2 of the Agreement is hereby amended by deleting Section 7.2 in its entirety and replacing it with the following:  “7.2 RESERVED. “

 

3.             Section 7.3 of the Agreement is hereby amended by deleting Section 7.3 in its entirety and replacing it with the following:  “7.3 RESERVED. “

 

4.             Section 7.4 of the Agreement is hereby amended by deleting Section 7.4 in its entirety and replacing it with the following:  “7.4 RESERVED. “

 

5.             Section 7.5 of the Agreement is hereby amended by deleting Section 7.5 in its entirety and replacing it with the following:  “7.5 RESERVED. “

 

6.             Section 8 of the Agreement is hereby amended by deleting clause (c) thereof in its entirety, deleting “; and” in the sixth line thereof and inserting “and” in the fifth line immediately before “(b)”.

 

7.             The Agreement is hereby amended by deleting all references to the sections of the Agreement deleted in their entirety hereby.

 

8.             Except to the extent amended hereby, all of the definitions, terms, provisions and conditions set forth in the Agreement are hereby ratified and confirmed and shall remain in full force and effect.  The Agreement and this Amendment No. 1 shall be read and construed together as a single agreement and the term “Agreement” shall be deemed a reference to the Agreement as amended by this Amendment No. 1.  This Amendment No. 1 may be signed in any number of counterparts, each of which

 



 

shall be deemed to be an original and all of which together shall constitute but one and the same instrument.  In making proof of this Amendment No. 1 it shall not be necessary to produce or account for more than one such counterpart.

 

IN WITNESS WHEREOF, the parties have executed under seal and delivered this Agreement as of the date first written above.

 

 

THE CORPORATION:

 

 

 

RADIUS HEALTH, INC.

 

 

 

By:

/s/ C. Richard Edmund Lyttle

 

 

Name: C. Richard Edmund Lyttle

 

 

Title: President

 

 

 

 

 

As an anticipated successor and assign to the Corporation under Section 16 hereof:

 

 

 

MPM ACQUISITION CORP.

 

 

 

 

 

By:

/s/ C. Richard Edmund Lyttle

 

 

Name: C. Richard Edmund Lyttle

 

 

Title: President

 



 

 

INVESTORS:

 

 

 

BB Biotech Ventures II, L.P.

 

 

 

By:

BB Biotech Ventures Guernsey Ltd

 

 

Its General Partner

 

 

 

 

By:

/s/ Pascal Mahieux

 

 

Name: Pascal Mahieux

 

 

Title: Director

 

 

 

 

 

BB Biotech Growth N.V.

 

 

 

By:

/s/ Jan Bootsma

 

 

Name: Jan Bootsma

 

 

Title: Managing Director

 

 

 

 

HEALTHCARE VENTURES VII, L.P.

 

By:

HealthCare Partners VII, L.P.

 

 

Its General Partner

 

 

 

 

By:

/s/ Jeffrey Steinberg

 

 

Name:

Jeffrey Steinberg

 

 

Title:

Administrative Partner of HealthCare Partners VII, L.P.

 

 

 

The General Partner of HealthCare Ventures VII, L.P.

 

 

 

 

 

HEALTHCARE PRIVATE EQUITY LIMITED PARTNERSHIP acting by its general partner Waverley Healthcare Private Equity Limited

 

 

 

 

 

 

 

By:

/s/ Andrew November

 

 

Name: Andrew November

 

 

Title: Authorized Signatory

 



 

 

MPM BIOVENTURES III, L.P.

 

 

 

By:

MPM BioVentures III GP, L.P.,

 

 

its General Partner

 

By:

MPM BioVentures III LLC,

 

 

its General Partner

 

 

 

By:

/s/ Ansbert Gadicke

 

 

Name: Ansbert Gadicke

 

 

Title: Series A Member

 

 

 

 

 

MPM BIOVENTURES III-QP, L.P.

 

 

 

By:

MPM BioVentures III GP, L.P.,

 

 

its General Partner

 

By:

MPM BioVentures III LLC,

 

 

its General Partner

 

 

 

 

By:

/s/ Ansbert Gadicke

 

 

Name: Ansbert Gadicke

 

 

Title: Series A Member

 

 

 

 

 

 

 

MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG

 

 

 

By:

MPM BioVentures III GP, L.P.,

 

 

in its capacity as the Managing

 

 

Limited Partner

 

By:

MPM BioVentures III LLC,

 

 

its General Partner

 

 

 

By:

/s/ Ansbert Gadicke

 

 

Name: Ansbert Gadicke

 

 

Title: Series A Member

 



 

 

MPM BIOVENTURES III PARALLEL

 

FUND, L.P.

 

 

 

By:

MPM BioVentures III GP, L.P.,

 

 

its General Partner

 

By:

MPM BioVentures III LLC,

 

 

its General Partner

 

 

 

 

By:

/s/ Ansbert Gadicke

 

 

Name: Ansbert Gadicke

 

 

Title: Series A Member

 

 

 

 

 

MPM ASSET MANAGEMENT

 

INVESTORS 2003 BVIII LLC

 

 

 

By:

/s/ Ansbert Gadicke

 

 

Name: Ansbert Gadicke

 

 

Title: Manager

 

 

 

 

 

MPM BIO IV NVS STRATEGIC FUND, L.P.

 

 

 

By:

MPM BioVentures IV GP LLC,

 

 

its General Partner

 

By:

MPM BioVentures IV LLC,

 

 

its Managing Member

 

 

 

 

By:

/s/ Ansbert Gadicke

 

 

Name: Ansbert Gadicke

 

 

Title: Member

 

 

 

 

 

SAINTS CAPITAL VI, L.P.,

 

a limited partnership

 

 

 

 

By:

Saints Capital VI LLC,

 

a limited liability company

 

 

 

 

By:

/s/ David P. Quinlivan

 

 

Name: David P. Quinlivan

 

 

Title: Managing Member

 



 

 

BROOKSIDE CAPITAL PARTNERS FUND, L.P.

 

 

 

 

 

 

 

By:

/s/ Ranesh Ramanathan

 

 

Name: Ranesh Ramanathan

 

 

Title: General Counsel

 

 

 

 

The Breining Family Trust dated August 15, 2003

 

 

 

 

 

 

 

By:

/s/ Clifford Breining

 

 

Name: Clifford Breining

 

 

Title: Trustee

 

 

 

 

The Richman Trust dated 2/6/83

 

 

 

 

 

 

 

By:

/s/ Douglas Richman

 

Name: Douglas D. Richman

 

Title: Co-Trustee

 

 

 

 

 

 

 

By:

/s/ Eva A. Richman

 

Name: Eva A. Richman,

 

Title: Co-Trustee

 

 

 

 

THE WELLCOME TRUST LIMITED, AS TRUSTEE OF THE WELLCOME TRUST

 

 

 

 

 

By:

/s/ Peter Pereira Gray

 

Name: Peter Pereira Gray

 

Title: Managing Director

 

 

 

/s/ Raymond F. Schinazi

 

Dr. Raymond F. Schinazi

 

 

 

 

/s/ H. Watt Gregory III

 

H. Watt Gregory III

 

 

 

The David E. Thompson Revocable Trust

 

 

 

 

 

By:

/s/ David E. Thompson

 

Name: David E. Thompson

 

Title: Trustee